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Estrogens in the Environment
On 20-23 July 1997, the NIEHS hosted the
latest in its series ofconferences on estrogen,
"Estrogens in the Environment IV," in
Arlington, Virginia. Approximately 400 par-
ticipants attended, including policy makers
and internationally recognized scientists from
U.S. government agencies, the chemical
manufacturing industry, academia, and a
broad spectrum ofscientific disciplines. The
conference was co-sponsored by the NIH's
Office of Research on Women's Health, the
National Center for Environmental Health at
the CDC, the Society for the Advancement
ofWomen's Health Research, and the EPA.
NIEHS director Kenneth Olden stressed
the NIEHS's continuing leadership in
research on estrogens and environmental
health and outlined the goal of the confer-
ence-linking strong science to regulatory
decision-making. Olden stressed the need for
collaboration between scientists and govern-
ment agencies to improve public health poli-
cies. New research priorities stated at the
meeting include improved understanding of
estrogen's effects on reproduction and fetal
growth, more effective risk assessment meth-
ods, and increased attention to effects oflow-
dose exposures.
Estrogens are steroid hormones-chemi-
cals that are important in human brain,
reproduction, and bone development-and
are produced by the endocrine system.
Estrogens are also present in the environ-
ment, both from natural sources like plants
and fungi and as a by-product of synthetic
chemicals. Environmental estrogens includ-
ing DDT, some by-products ofplastic man-
ufacturing, and PCBs are often referred to as
"endocrine disrupters" because oftheir abili-
ty to mimic, halt, or alter endocrine function
in animals and humans exposed to them.
There are at least 50 environmental chemi-
cals that exhibit estrogenic activity. In
wildlife, estrogenic chemicals have been
shown to cause birth defects and reproduc-
tive abnormalities. Human hormone recep-
tor systems are similar to those in animals so
wildlife effects raise concern for human
health. "It's well established that environ-
mental estrogens can pose a health hazard,"
said Cheryl Walker, associate professor at the
University of Texas in Smithville. "But we
still have to define whether they are a risk,
and characterize the risk." Some plant estro-
gens may in fact be beneficial to health, so
evaluation ofhealth effects is difficult.
Diseases and dysfunctions that occur at
hormonally sensitive receptor sites, such as
breast cancer, testicular cancer, and decreas-
ing sperm counts, are reported to be increas-
ing, although these trends have not been
clearly linked to endocrine-disrupting chemi-
Estrogenic effluent? Scientists estimate that at
least 50 different chemicals, many of which
are discharged into the environment, exhibit
estrogenic activity.
cals. The White House and government
agencies have named environmental estro-
gens as a priority concern for human and
environmental health.
Researchers at the conference summa-
rized the current state ofknowledge ofnatur-
al and environmental estrogens. Researchers
now have an improved understanding of
how estrogen and other hormones may func-
tion in cells and tissues. Speakers stated that
environmental estrogens may affect repro-
ductive functions in particular, and may
cause irreversible changes in developing
fetuses. However, questions remain includ-
ing what levels ofspecific estrogens are toxic.
The relationships between effects of estro-
gens in animals and those in humans, and
what are the effects, if any, ofcombinations
ofmultiple estrogen exposures have yet to be
clarified. Children have been shown to be
more sensitive to the adverse effects of
endocrine disrupters than adults. NewWhite
House directives mandate research on pre-
and postnatal effects ofenvironmental estro-
gen exposures.
Speakers from the Food and Drug
Administration and the EPA expressed eager-
ness for scientific input in the development
of environmental and public health policies.
Individual and interagency groups have allot-
ted over $40 million for research on environ-
mental estrogens. Particular research needs
include improved substance screening
methodologies, chemical-specific data, better
human exposure data, and predictive
research on chemical effects.
New evidence about low-dose exposures
presented at the meeting highlighted the
need for new screening methods for the
effects of estrogens. Frederick vom Saal of
the University ofMissouri's division of bio-
logical sciences in Columbia demonstrated
that extremely low doses ofestrogens (up to
50 times lower than levels considered safe by
the American Cancer Society) can cause sig-
nificant hormonal changes. Present tests,
which measure toxicity based on maximum
exposure levels, do not address the complex
nature and interactions of estrogens.
Participants stressed the need to develop risk
assessment procedures that speak to the
effects of low-dose exposures. Jon C. Cook
of DuPont's Stine-Haskell Laboratories of
Newark, Delaware, described new screening
methods being developed to improve detec-
tion of toxicity in environmental estrogens.
New screening methods, combined with
improved understanding of low-dose
responses, will help researchers characterize
the risks associated with exposures to various
estrogens.
Other presentations showed that
improved understanding of the complex
functions of estrogens is pointing to new
avenues for research and therapy. Bert
O'Malley, director of the Baylor College of
Medicine in Houston, Texas, showed that as
many as nine chemicals (both within and
outside the body) contribute to the activa-
tion of hormones. Human hormones inter-
act differently and at varying magnitudes,
with different types of environmental estro-
gens functioning as agonists in some tissue
and as antagonists in others. For example,
the synthetic hormone tamoxifen may initi-
ate hormonal activities in bone, while curtail-
ing it in breast tissues. "The next step is to
identify and clone the full complement of
co-activators [of estrogen-like chemicals],"
O'Malley said. Future NIEHS workshops
will address ways of researching low-dose
response and multiple chemical effects.
Speakers indicated that they are close to
defining the full range ofchemicals and mol-
ecules that interact with hormone receptor
signaling pathways and are gaining a clearer
understanding ofhow these chemicals inter-
act with cellular pathways. With this infor-
mation, researchers may be able to develop
new therapies for hormonally induced ill-
nesses such as cancer. Overall, the conference
reflected a much clearer understanding ofthe
number, diversity, and pervasiveness ofenvi-
ronmental estrogens, according to George
Stancel, pharmacology chairman at the
University of Texas Medical School in
Houston. "What we need now is an unam-
biguous statement of the problem, with a
clear link to policy," he said.
Volume 105, Number9, September 1997 * Environmental Health Perspectives 910